TITAN PHARMACEUTICAL (TTP) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
TITAN PHARMACEUTICAL (TTP)

An SI Board Since February 1997

Posts	SubjectMarks	Bans	Symbol
362	31	0	TTP

Emcee: matt wolf	Type: Unmoderated

Introduction Market Data Compact

Does anyone have any info on this company? I have heard they have quite a few things pending with the FDA. The stock seems to be way down from it's year high. Is their a reason for this or is this a good time to buy? thanks, matt

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
362	Titan Announces FDA Approval of Fanapt(TM) (Iloperidone) For the Treatment of Sc	sjemmeri	-	5/7/2009
361	Titan Pharmaceuticals Announces Board Decision to Delist Common Stock and Deregi	kenhott	-	12/4/2008
360	Iloperidone now being discussed as blockbuster potential. Looks like the windy r	bioreasearcher	-	10/9/2007
359	Titan Announces Filing of Iloperidone NDA SOUTH SAN FRANCISCO, Calif.--(BUSINES	nigel bates	-	10/1/2007
358	Titan Annnounces Completion of Patient Enrollment in Randomized Phase IIb Clinic	kenhott	-	6/28/2007
357	Titan Pharmaceuticals Files $50M Stock Shelf	sjemmeri	-	2/8/2007
356	Man, that was fast. You answered before I finished my 15th edition. Nobody is g	kenhott	-	12/8/2006
355	I agree with you. But have no idea on timing, could be some time before the next	rkrw	-	12/8/2006
354	They won't get iloperidone approved the way they are heading. Then you have	kenhott	-	12/8/2006
353	If the safety profile is very clean (apart from the QT stuff), Iloperidone ought	DewDiligence_on_SI	-	12/7/2006
352	Titan Reports Positive Results in Iloperidone Phase III Clinical Trial Dec 7,	LJM	-	12/7/2006
351	Probably the correct call. Though I think probuphine looks interesting. Vanda	rkrw	-	12/7/2006
350	Didn't want to continue to mess up GENT board... so finish the thought here.	kenhott	-	12/7/2006
349	TTP starts probuphine phase 3 stops DITPA phase 2 for CHF. Titan Initiates Phas	kenhott	-	10/25/2006
348	Q: Where they were in December? A: Spavali zimski san! Miljenko	Miljenko Zuanic	-	3/17/2006
347	Titan Pharmaceuticals to Raise $10 Million in Registered Direct Offering of Comm	tnsaf	-	3/16/2006
346	Richard Allen leaves TTP. See latest Q report.	kenhott	-	3/14/2006
345	Bearing in mind the (tiny) market cap. at the start of the year, anything vaguel	nigel bates	-	3/9/2006
344	I would suggest caution about putting too much weight behind DITPA for CHF. It	kenhott	-	3/9/2006
343	I'm wondering if DITPA is the dark horse here. Certainly lots of very intere	Biomaven	-	3/9/2006
342	Titan Initiates Controlled Phase II Clinical Study of DITPA in the Treatment of	nigel bates	-	3/7/2006
341	Would anyone have a good idea about the current runnup? Buyout? Fast track? Ap	SilasSan	-	3/6/2006
340	Thanks Steve, this was news to me and interesting one at that. And if this is re	Alfred W. Post	-	3/3/2006
339	I do not know what's driving it. The upturn followed this news on Dec 15: Me	sjemmeri	-	2/24/2006
338	Hi, do you have any information why the stock is increasing so nicely? Way back	Alfred W. Post	-	2/24/2006

Go to reply# or date (mm/dd/yy):